ABT-100 - CAS# 450839-40-4 60183 PF-04457845 inhibits the pain response

PF-04457845 inhibits the pain response to a comparable degree as the nonsteroidal anti-inflammatory drug naproxen at 10 mg/kg

autophagy and cellular senescence during Osteoarthritis (OA)

Smiles: CC1=NN(C)C2OC(N)=C(C#N)C(C1=2)C1C=CC(=CC=1)C(F)(F)F

is a apotent tau aggregation inhibitor for the treatment of Alzheimer's disease (AD) and frontotemporal dementia

and also owing to its anti-inflammatory effect

ABT-100 - CAS# 450839-40-4 60183 PF-04457845 inhibits the pain responseABT 100, CAS No. 450839 40 4, is an orally bioavailable farnesyltransferase inhibitor. ABT 100 inhibited proliferation of cells in vitro carrying oncogenic H Ras (EJ 1 bladder; IC(50) 2. 2 nmol L), Ki Ras (DLD 1 colon, MDA MB 231 breast, HCT 116 colon, and MiaPaCa 2 pancreatic; IC(50) range, 3. 8 9. 2 nmol L), and wild type Ras (PC 3 and DU 145; IC(50), 70 and 818 nmol L, respectively) as well as clonogenic potential. ABT 100 shows 70% to 80% oral